Xeris Pharmaceuticals | Profitto Lordo Sulle Vendite



Gross Profit On Sales Cambiamento Data
Adcock Ingram Holdings ZAR 1.54B 73.26M 2024-12
Celltrion KRW 442.87B 100.93B 2025-03
Cspc Pharmaceutical CNY 4.71B 391.66M 2025-03
Dianthus Therapeutics 193K 970K 2025-06
Divis Laboratories Ltd 14.54B 1.5B 2025-06
Eli Lilly USD 13.11B 2.61B 2025-06
Kangmei Pharma CNY 223.73M 38.54M 2025-03
Knight Therapeutics CAD 45.02M 2.32M 2024-09
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Malin Corporation EUR 3.8M 2.6M 2020-12
Medical Developments International AUD 14.72M 1.36M 2024-12
Organigram Holdings CAD 26.15M 25.1M 2025-06
Pacira USD 125.91M 8.71M 2025-06
Perrigo USD 362.9M 29.4M 2025-06
Pharma Mar EUR 53.61M 18.15M 2025-06
Qiagen NV USD 334.29M 25.6M 2025-06
Sartorius EUR 416.2M 14.8M 2025-06
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Supernus Pharmaceuticals USD 127.81M 6.25M 2025-06
Tilray USD 61.22M 1.51M 2024-11
Zz Pientze Pharmaceu 296.13M 1.1B 2025-06


Xeris Pharmaceuticals Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.